Colorectal cancer research in young adults

Recent scientific studies have identified distinct biological and genetic characteristics in colorectal cancer patients under the age of 50. Research published in Nature Medicine indicates that tumors in younger individuals may possess a more aggressive microenvironment, which potentially contributes to advanced diagnoses and resistance to standard chemotherapy and immunotherapy. Kimmie Ng of the Dana-Farber Cancer Institute noted that patients under 35 often face lower survival rates despite being generally healthier.

An international study led by Italian scientists has further identified a “placental signature” in these younger patients. This signature consists of specific proteins associated with embryonic and placental development that interact with the immune system and facilitate tissue invasion. The research also found that Hervh sequences, derived from ancient viruses integrated into human DNA, become reactivated in these tumors. Researchers clarified that the placenta does not cause the cancer, but rather that similar cellular functions are being reactivated. While these findings provide new insights into the rising incidence of early-onset colorectal cancer, current patient therapies remain unchanged.